Overview

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for the treatment of cardio-metabolic, liver and oncological diseases. The company leverages its proprietary drug discovery approach to tackle serious health issues, creating a robust pipeline of innovative drug candidates.

Therapeutic areas

cardio-metabolic diseasesliver diseasesoncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NGM Biopharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.